Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets. Our mission is to become the world leader in developing better and safer antibody-based oncology products addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.
View Top Employees from Y-mAbs Therapeutics, Inc.| Website | http://www.ymabs.com |
| Ticker | YMAB |
| Revenue | $7 million |
| Funding | $434.2 million |
| Employees | 131 (131 on RocketReach) |
| Founded | 2015 |
| Address | 230 Park Avenue 3350, New York, New York 10169, US |
| Phone | (646) 885-8505 |
| Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Drug Discovery |
| Web Rank | 8 Million |
| Keywords | Biopharmaceuticals, Oncology, Cancer Treatment |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 54138 Companies, NAICS Code 5413 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Y-mAbs Therapeutics, Inc. employee's phone or email?
Y-mAbs Therapeutics, Inc. Questions
The Y-mAbs Therapeutics, Inc. annual revenue was $7 million in 2024.
131 people are employed at Y-mAbs Therapeutics, Inc..
Y-mAbs Therapeutics, Inc. is based in New York, New York.
The NAICS codes for Y-mAbs Therapeutics, Inc. are [54138, 5413, 541, 54].
The SIC codes for Y-mAbs Therapeutics, Inc. are [283, 28].
Top Y-mAbs Therapeutics, Inc. Employees
-
52
-
ViewAmy Graffum Olvera
VP of Marketing at Y-mAbs Therapeutics, Inc.
New York, New York, United States35 -
21
-
View
Anna Murzhenko
Head of Medical Affairs, Vice President at Y-mAbs Therapeutics, Inc.
New York, NY, US25 -
View
Bo Kruse
Chief Financial Officer at Y-mAbs Therapeutics, Inc.
Copenhagen, Capital Region, Denmark14 -
45+
-
35
-
31
Related Companies
